Search for: "Hatch v. State Bar"
Results 161 - 180
of 183
Sorted by Relevance
|
Sort by Date
18 Feb 2010, 10:34 am
Buckman bars fraud on the FDA claims, no matter what their purported statutory basis. [read post]
2 May 2008, 7:00 am
Landmark IP implications for universities: University of Western Australia v Gray: (IPRoo), (Managing Intellectual Property), (The Age), The latest edition of US Trade Representative’s ‘Special 301 Report’: (Ars Technica), (Ars Technica), (IAM), (Intellectual Property Watch), (Patry Copyright Blog), (Managing Intellectual Property), (Patent Docs), (IP Law360), Court rejects RIAA ‘making available’ theory: Atlantic v Howell:… [read post]
9 Nov 2010, 3:09 pm
(collectively, "Barr") filed an Abbreviated New Drug Application ("ANDA") with a Paragraph IV certification under the Hatch-Waxman Act, 21 U.S.C. [read post]
17 Jan 2018, 10:04 am
I don’t have a clear vision of which group will prevail or how the SESTA v. [read post]
17 Jan 2018, 10:04 am
I don’t have a clear vision of which group will prevail or how the SESTA v. [read post]
26 Feb 2013, 5:01 pm
Specifically, under the PCT this is a formal deficiency under Article 14(1)(a)(v) in combination with Rule 11.13(a), which can be remedied upon invitation under Article 14(1)(b). [read post]
21 Mar 2019, 10:43 am
., L.P. v. [read post]
7 May 2010, 10:00 pm
Paul, Rust v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
2 Feb 2024, 6:51 am
Supreme Court’s landmark decision in Trump v. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
20 Nov 2007, 8:55 am
Hatch, Mr. [read post]
11 Feb 2021, 2:35 pm
It states, without any equivocation, that there is "no precedent. [read post]
12 Mar 2012, 4:07 am
In Rozenblat v. [read post]
14 Jul 2015, 2:50 pm
In United States v. [read post]
9 Mar 2020, 1:21 pm
Seen this before w/Hatch-Waxman w/communications about generics suggesting they were outdated or less effective. [read post]
25 Dec 2017, 9:40 pm
Supreme Court’s recent decision in Endrew F. v. [read post]
25 Dec 2017, 9:40 pm
Supreme Court’s recent decision in Endrew F. v. [read post]
29 Oct 2012, 12:18 pm
§ 314.94(a)(12)(v), “if the [ANDA] is for a drug or method of using a drug claimed by a patent and the applicant has a licensing agreement with the patent owner,” the application must contain a Paragraph IV certification as to that patent “and a statement that it has been granted a patent license. [read post]
29 Jul 2014, 4:21 pm
As compared to the House bill, the Leahy bill would raise the bar on what such applications must state. [read post]
